Get Ahead with IPO Insights, IPO Prophet

IPO Prophet

Get Ahead with IPO Insights

At IPO Prophet®, our team leverages over three decades of expertise to deliver actionable quantitative analytics for the IPO market in real-time. This platform synthesizes our extensive experience investing in IPOs, providing investors with revolutionary tools to navigate the complexities of issuance day. Our mission is to empower investors with data-driven insights to make more informed decisions.

Equity Capital Markets

<ul><li>Medline Inc., the Northfield, Illinois–based medical products manufacturer and distributor, is advancing toward one of 2025’s largest IPOs.</li><li>The company plans to raise $5.0 billion by offering 179 million Class A shares at a price range of $26–$30, with an expected listing on the Nasdaq Global Select Market under the ticker MDLN.</li><li>At the midpoint valuation of $28, Medline would command a fully diluted market capitalization of approximately $37.3 billion, positioning it among the year’s most significant offerings.</li></ul>

Medline Inc., the Northfield, Illinois–based medical products manufacturer and distributor, is advancing toward one of 2025’s largest IPOs.The company plans to raise $5.0 billion by offering 179 million Class A shares at a price range of $26–$30, with an expected listing on the Nasdaq Global Select Market under the ticker MDLN.At the midpoint valuation of $28, Medline would command a fully diluted market capitalization of approximately $37.3 billion, positioning it among the year’s most significant offerings.

Medline Aims for a $5 Billion IPO as America’s Largest Privately Held Medical Supplier

US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

US IPOs and Secondary Offerings

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

IPOs and Secondary Offerings

<ul>
<li>Medline targets up to $5.4B in its IPO, the largest potential cash-raise since Rivian in 2021.</li>
<li>Strong anchor and cornerstone commitments signal deep institutional support ahead of one of the year’s most anticipated offerings.</li>
<li>Medline’s resilient, high-margin med-surg platform delivers consistent organic growth, reinforcing its profile as a mature, scaled issuer.</li>
</ul>


Medline targets up to $5.4B in its IPO, the largest potential cash-raise since Rivian in 2021.
Strong anchor and cornerstone commitments signal deep institutional support ahead of one of the year’s most anticipated offerings.
Medline’s resilient, high-margin med-surg platform delivers consistent organic growth, reinforcing its profile as a mature, scaled issuer.


Medline Inc. (MDLN): Hospital Product & Supply Chain Company Sets Terms on Mega IPO, $5b+ Cash Raise

<ul>
<li>Through their two segments, Medline Brand and Supply Chain Solutions, they offer approximately 335,000 med-surg products.</li>
<li>They had net sales of $21.4  billion, $23.2 billion, and $25.5 billion and net income (loss) of ($25 million), $234 million, and $1.2 billion in 2022, 2023, and 2024, respectively.</li>
<li>This company is a staple to the healthcare and hospitals industry and we anticipate a market cap north of $50 billion.</li>
</ul>


Through their two segments, Medline Brand and Supply Chain Solutions, they offer approximately 335,000 med-surg products.
They had net sales of $21.4  billion, $23.2 billion, and $25.5 billion and net income (loss) of ($25 million), $234 million, and $1.2 billion in 2022, 2023, and 2024, respectively.
This company is a staple to the healthcare and hospitals industry and we anticipate a market cap north of $50 billion.


Medline Inc. (MDLN): Peeking at the IPO Prospectus of Mega Hospitals Product & Supply Chain Company

United States

Medline Industries is a medical supply company, manufacturer and distributor.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medline (MDLN US)

Medline Aims for a $5 Billion IPO as America’s Largest Privately Held Medical Supplier

Backed by a century of family stewardship and a modern private-equity partnership, Medline is turning its integrated healthcare supply chain into...

IPO Prophet

Medline Inc. (MDLN): Hospital Product & Supply Chain Company Sets Terms on Mega IPO, $5b+ Cash Raise

Medline aims for $5.4B in IPO, backed by strong institutional support, with a proven track record of consistent organic growth.

IPO Boutique

Medline Inc. (MDLN): Peeking at the IPO Prospectus of Mega Hospitals Product & Supply Chain Company

Medline, a key player in healthcare, offers a wide range of medical products and is projected to reach a market cap exceeding $50 billion.

IPO Boutique

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Medline Aims for a $5 Billion IPO as America’s Largest Privately Held Medical Supplier

Backed by a century of family stewardship and a modern private-equity partnership, Medline is turning its integrated healthcare supply chain into...

IPO Prophet

Medline Inc. (MDLN): Hospital Product & Supply Chain Company Sets Terms on Mega IPO, $5b+ Cash Raise

​Medline aims for $5.4B in IPO, backed by strong institutional support, with a proven track record of consistent organic growth.

IPO Boutique

Medline Inc. (MDLN): Peeking at the IPO Prospectus of Mega Hospitals Product & Supply Chain Company

​Medline, a key player in healthcare, offers a wide range of medical products and is projected to reach a market cap exceeding $50 billion.

IPO Boutique

Medline aims for $5.4B in IPO, backed by strong institutional support, with a proven track record of consistent organic growth.

Medline, a key player in healthcare, offers a wide range of medical products and is projected to reach a market cap exceeding $50 billion.